Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Bringing in experts from diverse specialties like industrial engineering, pharmacy, and informatics, the Brain Safety Lab aims to develop strategies to reduce brain harm and increase safety both within and outside of the health industry.

Brain Safety Lab is funded by a $4 million grant from Agency for Healthcare Research and Quality to the Indiana University Center for Aging Research.

The Brain Health Patient Safety Learning Laboratory will start with two elder-focused projects – patient safety with anticholinergics (led by Drs. Malaz Boustani and Noll Campbell) and preventing hypoglycemia in seniors with diabetes (led by Dr. Michael Weiner).

The BSL project focusing on safely deprescribing anticholinergic medications, finished patient recruitment in February. Design research, including computer simulations, is currently underway. The project studying methods for preventing hypoglycemia in diabetic adults, is set to begin recruitment in May.

Once these projects are have completed recruitment, the Brain Safety Lab will launch new projects and expand its scope to other threats to brain health, such as dietary habits and depression management.

Center for Aging Research
December 20, 2016 • News
Commonly used drugs lead to more doctor’s office, hospital and emergency department visits
Anticholinergic medications, a class of drugs commonly used by older adults, are linked to an increased rate of emergency department and hospital utilization in the United States, according to a study of community-dwelling Americans age 65 and older by the Center for Aging Research, Indiana University Center for Health Innovation and Implementation Science, and Regenstrief […]
Continue Reading >
Areas of Focus